Corcept Therapeutics Incorporated Shares Bought by Alps Advisors Inc.
| CORT Stock | USD 58.60 0.02 0.03% |
Slightly above 51% of Corcept Therapeutics' investor base is interested to short. The analysis of overall sentiment of trading Corcept Therapeutics Incorporated stock suggests that many investors are impartial at this time. Corcept Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Corcept Therapeutics' earnings reports, geopolitical events, and overall market trends.
Corcept |
Alps Advisors Inc. lifted its holdings in Corcept Therapeutics Incorporated by 1.4 percent during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 75,705 shares of the biotechnology companys stock after buying an additional 1,041 shares during
Read at thelincolnianonline.com
 |
Corcept Therapeutics Fundamental Analysis
We analyze Corcept Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corcept Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corcept Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Corcept Therapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Corcept Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Corcept Therapeutics stock to make a market-neutral strategy. Peer analysis of Corcept Therapeutics could also be used in its relative valuation, which is a method of valuing Corcept Therapeutics by comparing valuation metrics with similar companies.
Peers
Corcept Therapeutics Related Equities
| DYN | Dyne Therapeutics | 6.50 | ||||
| GLUE | Monte Rosa | 5.93 | ||||
| SNSE | Sensei Biotherapeutics | 5.66 | ||||
| ERAS | Erasca | 5.04 | ||||
| MLYS | Mineralys Therapeutics, | 4.71 | ||||
| NUVB | Nuvation Bio | 3.21 | ||||
| MGTX | MeiraGTx Holdings | 2.50 | ||||
| KROS | Keros Therapeutics | 2.02 | ||||
| RARE | Ultragenyx | 1.63 | ||||
| HALO | Halozyme Therapeutics | 1.42 | ||||
| IDYA | Ideaya Biosciences | 0.78 | ||||
| CYTK | Cytokinetics | 0.38 | ||||
| EWTX | Edgewise Therapeutics | 0.37 | ||||
| INSM | Insmed | 0.26 | ||||
| ANAB | AnaptysBio | 0.51 | ||||
| AGIO | Agios Pharm | 0.74 | ||||
| NXTC | NextCure | 2.50 |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.